Prospective Cohort Studies: A Guide to Design and Implementation

A prospective cohort study follows a defined group of people forward in time to observe who develops a specified outcome, with exposure status measured at enrollment before the outcome occurs. This design lets researchers estimate disease incidence and calculate relative risk, making it a foundational tool for studying causality in medicine, public health, and the life sciences. This guide walks through the essential steps of designing and implementing such a study, from defining the cohort to managing follow-up and data collection, and includes a practical planning checklist and timeline template.

What Defines a Prospective Cohort Study

A prospective cohort study selects subjects based on the presence or absence of an exposure and then follows them forward in time to determine who develops the outcome of interest. The investigator observes and records what happens without intervening to alter the outcome. This is the defining feature that separates cohort studies from experimental designs where the researcher actively assigns treatments or exposures.

Observational study designs fall into three common categories: cross-sectional, case-control, and cohort or longitudinal studies. In cross-sectional studies, exposure and outcome are measured at a single time point, which provides prevalence data and generates hypotheses but cannot establish temporal sequence. Case-control studies select subjects based on whether they have the outcome and then look backward to measure past exposures, reporting results as odds ratios with a higher risk of bias. Cohort studies, by contrast, are prospective in nature, select subjects based on exposure status, and determine outcomes at the end of follow-up. They provide incidence data and report the association between exposure and outcome as relative risk, making them useful for ascertaining causality. High dropout rates and confounding are the main problems encountered in these studies [6].

The prospective design offers a temporal view of groups and exposures that can uncover outcomes and associations that may be difficult to separate in smaller, traditional experiments. Several types of cohort designs exist, each with unique advantages, and they may be prospective or retrospective. Although most cohort designs are longitudinal, cross-sectional types are also useful in certain contexts. Selection of study participants and control groups must be made carefully, variables must be clearly defined and measurable, and investigators must be aware of potential biases and weaknesses associated with different cohort designs [10].

When to Choose a Prospective Cohort Design

Prospective cohort studies are appropriate when randomized controlled trials are not indicated or ethical to conduct. For many investigative questions, particularly those involving harmful exposures, rare outcomes, or long latency periods, randomization is either impossible or unethical. In these situations, observational studies may be the best available method. Well-designed observational studies have been shown to provide results similar to those of randomized controlled trials, challenging the belief that observational studies are second rate [8].

The design is particularly valuable for tracking outcomes in specific groups, such as patients with a particular disease, workers with a specific occupational exposure, or community residents with shared demographic characteristics. Cohort designs provide a temporal view that can reveal outcomes and exposures that may be difficult to separate in smaller experiments [10].

Prospective cohort data also serve a critical role in planning randomized trials. Simulations using data from a prospective cohort study can assess feasibility and operational challenges before launching a trial. In one case, data from 640 patients collected by a national spinal cord injury cohort were used to investigate scenarios of patient eligibility, study consent, and randomization list performance. The simulations showed that the recruitment target was obtainable within the envisioned time period under the most favorable scenario, identified imbalance in randomization lists that informed stratification cut-off values, and guided resource allocation based on patient influx patterns. Prospective cohort data are a very valuable resource for planning randomized controlled trials [12].

Core Principles of Cohort Definition

Defining the Source Population

The source population is the group from which you will draw your cohort. This definition determines the generalizability of your findings and shapes every subsequent design decision. Population-based cohorts draw from all eligible residents of a geographic area, while institution-based cohorts draw from patients at specific hospitals or clinics. The choice depends on your research question, available resources, and the outcome you intend to study.

The Qatar Biobank cohort provides an example of a population-based approach. Established in 2012, it aimed to recruit 60,000 adult Qataris or long-term residents who had lived in Qatar for at least 15 years, with follow-up every 5 years. The design was based on an agnostic hypothesis, collecting data using questionnaires, biological samples, imaging data, and omics technologies. By the time of reporting, the cohort had reached 28 percent of its target with more than 2 million biological samples, including 33 different nationalities with a relatively young, highly educated population [9].

The Japan Prospective Studies Collaboration for Aging and Dementia demonstrates a multisite population-based approach. Designed to enroll approximately 10,000 community-dwelling residents aged 65 years or older from 8 sites, the study collected baseline exposure data including lifestyles, medical information, diets, physical activities, blood pressure, cognitive function, blood tests, brain magnetic resonance imaging, and DNA samples using a pre-specified protocol and standardized measurement methods. The baseline survey enrolled 11,410 participants with a mean age of 74.4 years [25].

Setting Inclusion and Exclusion Criteria

Inclusion criteria define who can enter the cohort, and exclusion criteria define who cannot. These criteria must be objective, measurable, and applied consistently. For a study of community-dwelling adults, the Wako Cohort Study in Japan defined eligibility as adults aged 40 years or older living in a specific city. The study consisted of two surveys: a mail-in survey for persons aged 40 years and older and a face-to-face assessment for those aged 65 years and older. A total of 8,824 individuals participated in the mail-in survey, with 1,004 of those aged 65 years and older participating in the subsequent on-site survey [13].

For disease-specific cohorts, eligibility often centers on diagnosis or risk status. The Familial Pulmonary Fibrosis screening study included 200 asymptomatic first-degree family members of patients with the disease, who underwent three study visits over two years. The presence of interstitial lung disease changes on high-resolution computed tomography at baseline indicated preclinical disease, and comparisons were made between groups with and without these changes [21].

Distinguishing Exposure Groups

In a prospective cohort study, subjects are selected based on the presence or absence of exposure, and outcomes are determined at the end of follow-up [6]. Exposure definition must be precise and measurable at baseline. The Carriage of Multiresistant Bacteria After Travel study provides a clear example. The study aimed to determine the acquisition rate of multiresistant Enterobacteriaceae during foreign travel, the duration of carriage, transmission rates within households, and risk factors for acquisition and persistence. The cohort included 2,001 travelers and 215 non-traveling household members, with fecal samples collected before and immediately after travel and at 1 month after return, plus follow-up samples at 3, 6, and 12 months for those who acquired resistant bacteria [14].

Designing the Follow-Up Strategy

Determining Follow-Up Duration

Follow-up duration must be long enough for the outcome to develop but short enough to remain feasible and affordable. The appropriate duration depends on the natural history of the condition being studied. For dementia research, the Japan Prospective Studies Collaboration followed participants for at least 5 years to capture incident cases [25]. For metastatic colorectal cancer, the PROMETCO study collected data retrospectively and prospectively up to 18 months, enrolling 544 patients from 18 countries [7]. For pediatric palliative care, the SHARE study collected data at 6 timepoints over a 24-month follow-up period from 643 patients and their parents at seven children's hospitals [11].

Planning Follow-Up Contacts

The frequency and mode of follow-up contacts must balance data completeness against participant burden and cost. The DynAMoND study of affective dysregulation used a sophisticated approach with continuous smartphone data collection for one year, daily evening ratings of mood and sleep, and five intensive measurement periods of five days each where electronic diaries asked participants to report on mood, self-esteem, impulsivity, life events, social interactions, and dysfunctional behaviors ten times a day. Participants also wore activity sensors during the measurement bursts [23].

For less intensive studies, annual or semi-annual contacts may suffice. The CanProCo study of multiple sclerosis progression planned detailed clinical evaluation annually over 5 years, including advanced app-based clinical data collection, with a subset of 500 participants undergoing blood, cerebrospinal fluid, and other biological sampling [26].

Managing Participant Retention

High dropout rates are a recognized problem in cohort studies [6]. Retention strategies should be designed into the study from the start instead of added as an afterthought. The SHARE study's data infrastructure included centralized availability of multilingual questionnaires, electronic data collection and storage, time-stamping of instrument completion, and a separate but connected study administrative database used to track enrollment. These attributes supported consistent follow-up across seven sites [11].

Data Collection Methods and Instruments

Selecting Measurement Tools

Variables must be clearly defined and measurable [10]. The choice of measurement tools depends on the exposure and outcome of interest, the setting, and available resources. The Qatar Biobank collected data using questionnaires, biological samples, imaging data, and omics technologies, providing a model for comprehensive data collection [9]. The PROMETCO study collected patient-reported outcomes using the EuroQol 5-level 5-dimensional questionnaire, the Brief Fatigue Inventory, and a modified version of the ACCEPTance by their Treatment questionnaire, alongside clinical data on treatment patterns, effectiveness, and safety [7].

Standardizing Data Collection Protocols

Standardization is essential for data quality, particularly in multicenter studies. The Japan Prospective Studies Collaboration for Aging and Dementia used a pre-specified protocol and standardized measurement methods across all 8 sites, with brain magnetic resonance imaging performed using three-dimensional acquisition of T1-weighted images. The diagnosis of dementia was adjudicated by an endpoint adjudication committee using standard criteria and clinical information [25].

Linking Primary and Administrative Data

The SHARE study demonstrated the value of linking primary collected data to administrative data. Using medical record numbers, primary data were linked to administrative hospitalization data containing diagnostic and procedure codes and other data elements. This linkage enriched the dataset without additional participant burden and allowed for verification of self-reported outcomes [11].

Building the Data Management System

Centralized Data Storage

A centralized electronic data collection and storage system is a critical component of modern cohort studies. The SHARE study stored all data electronically in a centralized location, with time-stamping of instrument completion to track data collection timing and completeness. The system included a separate but connected study administrative database used to track enrollment, allowing investigators to monitor recruitment progress in real time [11].

Data Quality Controls

Quality assurance should be built into the data management system. The institution-based prospective inception cohort study design has been described with specific attention to implementation and quality assurance in pediatric thrombosis and stroke research [27]. Similar approaches have been applied in neonatal rare disease research [28]. These designs emphasize the importance of standardized data collection from the point of enrollment, regular monitoring of data completeness and accuracy, and clear protocols for handling missing or inconsistent data.

Multilingual and Accessible Instruments

For diverse populations, data collection instruments must be accessible to all participants. The SHARE study provided centralized availability of multilingual questionnaires, ensuring that participants with limited English proficiency could complete study measures accurately [11]. This consideration is particularly important for international or multicultural cohorts.

Statistical Considerations

Sample Size Calculation

Sample size must be sufficient to detect the expected effect size with adequate statistical power. The calculation depends on the expected incidence of the outcome in the unexposed group, the expected relative risk, the ratio of exposed to unexposed participants, and the acceptable error rates. For rare outcomes, larger cohorts or longer follow-up periods are needed.

The CanProCo study planned to recruit 1,000 individuals with radiologically-isolated syndrome, relapsing-remitting multiple sclerosis, and primary-progressive multiple sclerosis within 10 to 15 years of disease onset from 5 academic centers [26]. The Familial Pulmonary Fibrosis study planned to include 200 asymptomatic first-degree family members [21]. The DynAMoND study planned 480 participants aged 14 to 50, with 120 each from borderline personality disorder, attention-deficit/hyperactivity disorder, bipolar disorder, and healthy control groups [23].

Handling Confounding

Confounding is a recognized problem in cohort studies [6]. Confounders are variables associated with both the exposure and the outcome that can distort the observed association. Strategies for handling confounding include restriction, matching, stratification, and multivariable adjustment.

The ADVANCE cohort used frequency matching to address confounding, matching combat-injured participants to noninjured participants on deployment, service, rank, role, age, and ethnicity. This approach ensured that the exposed and unexposed groups were comparable on key characteristics [18].

Analyzing Time-to-Event Data

Because cohort studies follow participants over time, time-to-event analysis methods are often appropriate. These methods account for varying follow-up durations and censoring, where participants are lost to follow-up or do not experience the outcome by the end of the study. The Japan Prospective Studies Collaboration for Aging and Dementia planned to follow participants for at least 5 years and adjudicate dementia diagnoses by an endpoint committee, allowing for accurate determination of time to event [25].

Practical Implementation Steps

Step 1: Define the Research Question

Write a clear research question that specifies the population, exposure, outcome, and time frame. The question should be answerable with the resources available and should address a gap in existing knowledge. The COMBAT study provides an example with four specific aims: determine the acquisition rate of multiresistant Enterobacteriaceae during foreign travel, ascertain the duration of carriage, determine transmission rates within households, and identify risk factors for acquisition, persistence, and transmission [14].

Step 2: Conduct a Literature Review

Review existing evidence to confirm that the question has not already been answered and to identify established measurement tools and methods. The National Center for Biotechnology Information provides literature resources for this purpose [4], and PubMed offers access to the biomedical literature [5]. The EQUATOR Network provides reporting guidelines that can inform study design and eventual reporting [2].

Step 3: Define the Cohort

Specify the source population, inclusion criteria, exclusion criteria, and sampling method. Determine whether a population-based or institution-based approach is appropriate for your question. Consider whether an inception cohort, where all participants are enrolled at the same point in their disease or exposure course, is appropriate. Institution-based prospective inception cohort studies have been described in pediatric thrombosis and stroke research [27] and neonatal rare disease research [28].

Step 4: Define Exposure and Outcome Measures

Select validated measurement tools for all exposures and outcomes. Define outcomes using objective criteria where possible. For the Japan Prospective Studies Collaboration for Aging and Dementia, the primary outcome was the development of dementia and its subtypes, with diagnosis adjudicated by an endpoint committee using standard criteria [25].

Step 5: Calculate Sample Size

Determine the sample size needed to detect the expected effect with adequate power. Account for expected dropout rates by inflating the sample size accordingly. The CanProCo study planned to recruit 1,000 participants with a subset of 500 undergoing additional biological sampling, anticipating that not all participants would complete all study procedures [26].

Step 6: Design the Data Management System

Plan the data collection instruments, electronic data capture system, data storage, and quality control procedures. Consider whether linkage to administrative data is feasible and valuable. The SHARE study's data infrastructure included linkage of primary and administrative data, centralized multilingual questionnaires, electronic data collection and storage, time-stamping of instrument completion, and a separate study administrative database [11].

Step 7: Pilot the Study

Test all study procedures with a small sample of participants before full-scale implementation. The pilot should test recruitment materials, data collection instruments, laboratory procedures, and follow-up protocols. The Experimental Design Assistant from the NC3Rs can help with planning and visualizing study designs [3].

Step 8: Launch and Monitor

Begin enrollment and implement ongoing monitoring of recruitment, data quality, and follow-up completeness. Regular monitoring allows for early detection and correction of problems. The Research Data Framework from the National Institute of Standards and Technology provides guidance on managing research data throughout the study lifecycle [1].

At a Glance

Records and Measurements

Essential Records for Cohort Studies

Maintain a study master file containing the approved protocol, all versions of data collection instruments, standard operating procedures, and amendments. The master file should document every change to study procedures and the rationale for each change. The Research Data Framework provides guidance on managing research data throughout the study lifecycle, including documentation, storage, and sharing [1].

Tracking Enrollment and Follow-Up

Maintain a screening log that documents all individuals assessed for eligibility, including those who were excluded and the reasons for exclusion. The enrollment log should record the date of enrollment, assigned participant identifier, and baseline data completion status. The follow-up log should track each scheduled contact, the date completed, and any missed or rescheduled visits.

The SHARE study used a separate but connected study administrative database to track enrollment, allowing investigators to monitor recruitment progress across seven sites [11]. This approach can be adapted for studies of any size.

Documenting Data Collection

Each data collection event should be documented with the date, the person collecting the data, and the completeness of the data collected. Time-stamping of instrument completion, as used in the SHARE study, provides an objective record of when data were collected [11]. This documentation supports data quality assessment and allows for the identification of systematic problems with data collection.

Common Failure Patterns

Loss to Follow-Up

High dropout rates are a recognized problem in cohort studies [6]. Participants may withdraw, move away, or become too ill to continue. Loss to follow-up introduces bias if the participants who drop out differ systematically from those who remain. Strategies to minimize loss include maintaining current contact information, scheduling regular follow-up contacts, providing incentives, and using multiple modes of contact.

Measurement Error

Variables must be clearly defined and measurable [10]. Measurement error can occur when instruments are not validated, when protocols are not followed consistently, or when data are collected under varying conditions. Standardized protocols and regular training of data collectors can reduce measurement error.

Confounding

Confounding occurs when a variable is associated with both the exposure and the outcome, creating a spurious association or masking a real one [6]. The ADVANCE cohort used frequency matching on deployment, service, rank, role, age, and ethnicity to address confounding [18]. Multivariable adjustment is another common approach, but it requires accurate measurement of potential confounders.

Inconsistent Protocol Adherence

In multicenter studies, protocol adherence can vary across sites. The SHARE study addressed this by centralizing data collection and storage, providing multilingual questionnaires, and time-stamping instrument completion [11]. Regular monitoring and site visits can identify and correct protocol deviations.

Limitations and Tradeoffs

Time and Cost

Prospective cohort studies require substantial time and resources. Follow-up must be long enough for outcomes to develop, which can mean years or decades for chronic diseases. The Japan Prospective Studies Collaboration for Aging and Dementia planned follow-up of at least 5 years [25], while the Qatar Biobank planned follow-up every 5 years for a target of 60,000 participants [9].

Loss to Follow-Up

Despite best efforts, some participants will be lost to follow-up. The resulting bias depends on whether loss is related to both exposure and outcome. Statistical methods such as inverse probability weighting can address some of this bias, but they require assumptions about the missing data mechanism.

Changes in Exposure Over Time

Exposure status can change during follow-up. Participants may change their behavior, receive new treatments, or develop conditions that alter their exposure. The PROMETCO study addressed this by collecting data on treatment patterns over time in patients with metastatic colorectal cancer [7]. Analysis methods such as time-varying exposure models can accommodate these changes.

Generalizability

Findings from a cohort study may not generalize to populations that differ from the source population. The Qatar Biobank population was relatively young, highly educated, and had high monthly incomes, which may limit generalizability to other populations [9]. The Wako Cohort Study noted differences in health interests between men and women and across age groups [13].

Welfare and Safety Context

Participant Safety Monitoring

Cohort studies are observational and do not involve interventions, but they still require attention to participant safety. Studies that involve biological sampling, imaging, or other procedures must have protocols to address adverse events. The Japan Prospective Studies Collaboration for Aging and Dementia collected blood samples and performed brain magnetic resonance imaging, requiring protocols for handling incidental findings and procedure-related complications [25].

Data Confidentiality

Cohort studies collect sensitive health information that must be protected. Data should be stored securely, access should be limited to authorized personnel, and identifiers should be separated from clinical data where possible. The Research Data Framework provides guidance on managing research data, including security and sharing considerations [1].

Ethical Oversight

Prospective cohort studies require ethical approval from an institutional review board or research ethics committee. The CanProCo study design was approved by an international review panel comprised of content experts and key stakeholders [26]. Investigators should consult their institutional review board early in the design process to ensure compliance with applicable requirements.

Professional Escalation Criteria

When to Consult a Biostatistician

Consult a biostatistician early in the design process, before finalizing the sample size calculation or analysis plan. Additional consultation is warranted if you encounter unexpected patterns in the data, such as a higher than expected loss to follow-up, imbalance in exposure groups, or evidence of confounding that was not anticipated.

When to Consult a Data Management Specialist

Consult a data management specialist when designing the data collection and storage system, particularly for multicenter studies. The SHARE study's data infrastructure was designed with specific attention to linkage of primary and administrative data, centralized storage, and time-stamping of instrument completion [11]. A specialist can help ensure that the system meets these requirements.

When to Seek Protocol Amendments

Seek a protocol amendment when study procedures need to change to address emerging problems. Common reasons include difficulty meeting recruitment targets, higher than expected loss to follow-up, or the need to add or modify data collection instruments. Amendments should be documented in the study master file and approved by the appropriate oversight bodies.

Frequently Asked Questions

What is the difference between a prospective cohort study and a retrospective cohort study?

A prospective cohort study identifies the cohort at the present time and follows participants forward to observe outcomes that have not yet occurred. A retrospective cohort study identifies the cohort in the past using existing records and follows them forward to the present, with both exposure and outcome already determined. Prospective designs allow for standardized data collection and measurement of exposures before outcomes occur, while retrospective designs are faster and less expensive but rely on the quality of existing records [10].

How is a prospective cohort study different from a case-control study?

A prospective cohort study selects subjects based on exposure status and follows them forward to determine outcomes, reporting results as relative risk. A case-control study selects subjects based on the presence or absence of the outcome and measures past exposures, reporting results as odds ratios. Cohort studies provide incidence data and are useful for ascertaining causality, while case-control studies have a higher risk of bias [6].

What sample size do I need for a prospective cohort study?

The required sample size depends on the expected incidence of the outcome in the unexposed group, the expected relative risk, the ratio of exposed to unexposed participants, the acceptable error rates, and the expected dropout rate. Published cohort studies range from 150 participants in a single-center study of postdural puncture headache [22] to more than 11,000 participants in a multisite dementia study [25]. Consult a biostatistician to calculate the sample size for your specific study.

How long should follow-up last?

Follow-up duration must be long enough for the outcome to develop. The appropriate duration depends on the natural history of the condition. Studies of dementia have used follow-up of at least 5 years [25], studies of metastatic cancer have used 18 months [7], and studies of pediatric palliative care have used 24 months [11]. The duration should be specified in the protocol and justified based on the outcome of interest.

How do I handle participants who drop out of the study?

High dropout rates are a recognized problem in cohort studies [6]. Strategies to minimize dropout include maintaining current contact information, scheduling regular follow-up contacts, providing incentives, and using multiple modes of contact. In analysis, methods such as inverse probability weighting can address some of the bias introduced by dropout, but they require assumptions about the missing data mechanism.

What is an inception cohort?

An inception cohort enrolls all participants at the same point in the course of their disease or exposure, typically at diagnosis or at the onset of the condition. This design ensures that all participants are observed from a comparable starting point. Institution-based prospective inception cohort studies have been described in pediatric thrombosis and stroke research [27] and neonatal rare disease research [28].

Can prospective cohort data be used to plan randomized trials?

Yes. Simulations using prospective cohort data can assess feasibility and operational challenges before launching a randomized trial. In one case, data from 640 patients were used to investigate scenarios of patient eligibility and study consent, assess the performance of the randomization list, and guide resource allocation. Prospective cohort data are a very valuable resource for planning randomized controlled trials [12].

What reporting guidelines apply to prospective cohort studies?

The EQUATOR Network provides reporting guidelines for health research, including guidelines specific to observational studies [2]. Following these guidelines at the design stage can improve the quality of the eventual report. The National Center for Biotechnology Information provides literature resources [4] and PubMed provides access to the biomedical literature [5] for identifying relevant guidelines and examples.

Related Articles

• Bacterial Genome Annotation: A Practical Quality Checklist
• RNA-seq Library Preparation: Study Design and Quality Control
• RNA-seq Library Preparation: Study Design and Quality Control
• RNA-seq Library Preparation: Study Design and Quality Control
• CRISPR Experiment Design: Defining the Biological Question Before the Guide RNA

References and Further Reading

• Research Data Framework. National Institute of Standards and Technology.
• EQUATOR Network. EQUATOR Network.
• Experimental Design Assistant. NC3Rs.
• NCBI Literature Resources. National Center for Biotechnology Information.
• PubMed. National Library of Medicine.
• Study Design: Observational Studies.. Indian pediatrics, 2022.
• Rationale and design of the PROMETCO study: a real-world, prospective, longitudinal cohort on the continuum of care of metastatic colorectal cancer from a clinical and patient perspective.. Future oncology (London, England), 2022.
• Observational studies: cohort and case-control studies.. Plastic and reconstructive surgery, 2010.
• Qatar Biobank Cohort Study: Study Design and First Results.. American journal of epidemiology, 2019.
• A review of cohort study design for cardiovascular nursing research.. The Journal of cardiovascular nursing, 2009.
• The Design of a Data Management System for a Multicenter Palliative Care Cohort Study.. Journal of pain and symptom management, 2022.
• Optimizing clinical trial design using prospective cohort study data: a case study in neuro-urology.. Spinal cord, 2021.
• The Wako Cohort Study: Design and Profile of Participants at Baseline.. Journal of epidemiology, 2025.
• The Carriage Of Multiresistant Bacteria After Travel (COMBAT) prospective cohort study: methodology and design.. 2014.
• Effectiveness of enhanced recovery after surgery protocols in elderly patients undergoing major abdominal surgery: a systematic review and meta-analysis.. 2026.
• Cardiac Manifestation in Wilson Disease: Results of a 9-Year Prospective Cohort. 2026.
• Commentary: Development and validation of a multivariate predictive model for cancer-related fatigue in esophageal carcinoma: a prospective cohort study integrating biomarkers and psychosocial factors
• Novel Musculoskeletal Hypotheses in the Armed Services Trauma and Rehabilitation Outcome (ADVANCE) Cohort: Development and Application of Sparse Group Factor Analysis Methodology.. 2026.
• Photoacoustic-ultrasound endoscopy for assessment of rectal cancer treatment response: A prospective study with T2-weighted MRI radiomics comparison.. 2026.
• Intra- and peritumoral radiomics for predicting equivocal HER2 status of breast cancer on contrast-enhanced mammography.. 2026.
• Optimizing Screening for Early Disease Detection in Familial Pulmonary Fibrosis (FLORIS): A Prospective Cohort Study Design. Journal of Clinical Medicine, 2023.
• Incidence and risk factors of postdural puncture headache: prospective cohort study design. Perioperative Medicine, 2020.
• Dynamics of affect modulation in neurodevelopmental disorders (DynAMoND) - study design of a prospective cohort study. International Journal of Bipolar Disorders, 2024.
• Prevalence of Frailty Assessed by Fried and Kihon Checklist Indexes in a Prospective Cohort Study: Design and Demographics of the Kyoto-Kameoka Longitudinal Study.. Journal of the American Medical Directors Association, 2017.
• Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD). Environmental Health and Preventive Medicine, 2020.
• The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design. BMC Neurology, 2021.
• The institution-based prospective inception cohort study: Design, implementation, and quality assurance in pediatric thrombosis and stroke research. Seminars in Thrombosis and Hemostasis, 2013.
• Institution-based prospective inception cohort studies in neonatal rare disease research. Seminars in Fetal and Neonatal Medicine, 2011.
• Accurate identification of cohort study designs in perinatal research: a practical guide. American Journal of Obstetrics and Gynecology, 2022.
• Level 2 evidence: Prospective cohort study. Basic Methods Handbook for Clinical Orthopaedic Research A Practical Guide and Case Based Research Approach, 2019.

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.